Molbio Diagnostics Limited IPO: Issue Price, Listing Gain and Share Price Now
Molbio Diagnostics Limited listed on 17-Aug-2026 at ₹1,036.3 against an issue price of ₹807 , a listing gain of +28.41%. It last traded at ₹1,199.3 (25-Aug-2026). This page is the record of that issue and what has happened to it since — reported figures only.
Molbio Diagnostics Limited IPO: listing gain and return since
| Measure | Value |
|---|---|
| Issue price | ₹807 |
| Listing price (listing-day close) | ₹1,036.3 |
| Listing gain | +28.41% |
| Price now | ₹1,199.3 |
| Change from issue price | +48.61% |
| Change from listing-day close | +15.73% |
The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.
Molbio Diagnostics Limited IPO details
| Issue term | Detail |
|---|---|
| Issue price (upper band) | ₹807 |
| Issue size | ₹939.7 Cr |
| Fresh issue | ₹200.12 Cr |
| Offer for sale | ₹739.57 Cr |
| Lot size | 18 shares |
| Issue opened | 10-Aug-2026 |
| Issue closed | 12-Aug-2026 |
| Listed on | 17-Aug-2026 |
| Exchange | BSE, NSE |
| Segment | Mainboard |
| Lead managers | Kotak Mahindra Capital (left lead) |
| Registrar | Kfin Technologies Ltd. |
How the Molbio Diagnostics Limited IPO was subscribed
| Category | Subscription |
|---|---|
| QIB | 186.39x |
| NII | 49.80x |
| Retail | 12.97x |
| Total | 70.27x |
Molbio Diagnostics Limited today
| Figure | Value |
|---|---|
| Market capitalisation | ₹11,904 Cr |
| Trailing P/E | 71.20x |
| Return on capital employed | 18.5% |
| Return on equity | 15.6% |
| 52-week high | ₹1,177 |
| 52-week low | ₹926 |
| Sector | Medical Equipment & Supplies |
Fundamentals are as of the desk's last harvest and move with the market.
- Molbio Diagnostics Limited — full issue page: every stored figure, with its source.
- How many IPOs still trade above their issue price, corporate-action adjusted.
- The full IPO archive: listing gains by year, sector and issue size.
Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.
Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.
Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.